RENASANT CORP
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
RNST$40.19+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (Unaudited)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities | ||
| Net income | $102,324 | $150,710 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Provision for credit losses | 96,522 | 6,673 |
| Depreciation, amortization and accretion | 13,167 | 23,780 |
| Deferred income tax (benefit) expense | (4,103) | 2,494 |
| Gain on sale of MSR | (1,467) | (3,472) |
| Gain on sale of insurance agency | — | (53,349) |
| Funding of mortgage loans held for sale | (1,220,267) | (1,053,190) |
| Proceeds from sales of mortgage loans held for sale | 1,198,088 | 954,133 |
| Gains on sales of mortgage loans held for sale | (15,086) | (14,233) |
| Debt prepayment benefit | — | (56) |
| (Gains) losses on sales of premises and equipment | (347) | 11 |
| Stock-based compensation expense | 13,527 | 10,639 |
| Increase (decrease) in other assets | 251 | (8,108) |
| Decrease in other liabilities | (18,278) | (1,712) |
| Net cash provided by operating activities | 164,331 | 14,320 |
| Investing activities | ||
| Purchases of securities available for sale | (1,058,969) | (60,656) |
| Proceeds from sales of securities available for sale | 686,485 | 177,185 |
| Proceeds from call/maturities of securities available for sale | 203,429 | 66,310 |
| Proceeds from call/maturities of securities held to maturity | 78,918 | 76,170 |
| Proceeds from sale of MSR | 9,353 | 23,011 |
| Net increase in loans | (929,248) | (283,266) |
| Purchases of premises and equipment | (30,337) | (10,408) |
| Proceeds from sales of premises and equipment | 1,366 | 339 |
| Net cash received from sale of insurance agency | — | 55,333 |
| Proceeds from surrender of bank-owned life insurance | 56,255 | — |
| Net change in FHLB stock | (6,130) | 2,443 |
| Proceeds from sales of other assets | 12,605 | 1,466 |
| Net cash received in acquisition of businesses | 261,483 | — |
| Other, net | 3,836 | 656 |
| Net cash (used in) provided by investing activities | (710,954) | 48,583 |
| Financing activities | ||
| Net increase (decrease) in noninterest-bearing deposits | 46,584 | (53,874) |
| Net increase in interest-bearing deposits | 348,575 | 486,840 |
| Net increase (decrease) in short-term borrowings | 199,795 | (198,845) |
| Repayment of long-term debt | — | (245) |
| Cash paid for dividends | (56,578) | (39,510) |
| Proceeds from equity offering | — | 217,000 |
| Net cash provided by financing activities | 538,376 | 411,366 |
| Net (decrease) increase in cash and cash equivalents | (8,247) | 474,269 |
| Cash and cash equivalents at beginning of period | 1,092,032 | 801,351 |
| Cash and cash equivalents at end of period | $1,083,785 | $1,275,620 |
| Supplemental disclosures | ||
| Cash paid for interest | $324,630 | $286,930 |
| Cash paid for income taxes | $21,281 | $27,412 |
| Noncash transactions: | ||
| Transfers of loans to other real estate owned | $4,057 | $3,286 |
| Common stock issued in acquisition of businesses | $1,050,821 | $— |
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Recognition of operating right-of-use assets | $13,282 | $2,503 |
| Recognition of operating lease liabilities | $13,282 | $2,503 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.